These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33355105)

  • 1. Response to: 'Correspondence on 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'' by Aydin
    Freites Nuñez DD; Leon L; Mucientes A; Rodriguez-Rodriguez L; Font Urgelles J; Madrid García A; Colomer JI; Jover JA; Fernandez-Gutierrez B; Abasolo L
    Ann Rheum Dis; 2023 Mar; 82(3):e70. PubMed ID: 33355105
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to: 'Correspondence on 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'' by Schulze-Koops
    Freites Nuñez DD; Leon L; Mucientes A; Rodriguez-Rodriguez L; Font Urgelles J; Madrid García A; Colomer JI; Jover JA; Fernandez-Gutierrez B; Abasolo L
    Ann Rheum Dis; 2023 Jan; 82(1):e2. PubMed ID: 33127661
    [No Abstract]   [Full Text] [Related]  

  • 3. Correspondence to 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'.
    Schulze-Koops H; Skapenko A; Krause A; Krueger K; Lorenz HM; Sewerin P; Specker C; Wagner UG; Voormann A; Mueller-Ladner U; Voll RE
    Ann Rheum Dis; 2023 Jan; 82(1):e1. PubMed ID: 33127664
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to: 'Correspondence to 'Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases'' by Wu
    Pablos JL; Galindo M; Blanco R; Alvaro-Gracia JM
    Ann Rheum Dis; 2022 Dec; 81(12):e244. PubMed ID: 32978238
    [No Abstract]   [Full Text] [Related]  

  • 5. Correspondence on 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'.
    Aydin SZ; Hepworth E; Tugwell P
    Ann Rheum Dis; 2023 Mar; 82(3):e69. PubMed ID: 33355117
    [No Abstract]   [Full Text] [Related]  

  • 6. Correspondence to 'Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases'.
    Wu BY; Chan CH; Wei JC
    Ann Rheum Dis; 2022 Dec; 81(12):e243. PubMed ID: 32978235
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to 'Correspondence on 'Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort' by Ruyssen-Witrand
    Ciurea A; Finckh A
    Ann Rheum Dis; 2023 Feb; 82(2):e33. PubMed ID: 33177100
    [No Abstract]   [Full Text] [Related]  

  • 8. The outcome of COVID-19 in patients with autoimmune rheumatic diseases: Comparable to the general population or worse?
    Batu ED; Erden A
    Int J Rheum Dis; 2023 Aug; 26(8):1435-1439. PubMed ID: 37527023
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Gianfrancesco M; Hyrich KL; Yazdany J; Machado PM; Robinson PC
    Ann Rheum Dis; 2022 Oct; 81(10):e191. PubMed ID: 32796043
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic related group classification system as a new public health tool to predict risk and outcome of COVID-19 in patients with systemic rheumatic diseases: A population-based study of more than forty thousand patients.
    De Lorenzis E; Parente P; Natalello G; Soldati S; Bosello SL; Barbara A; Sorge C; Axelrod S; Verardi L; Cerasuolo PG; Peluso G; Gemma A; Davoli M; Biliotti D; Bruzzese V; Goletti M; Di Martino M; D'Agostino MA
    Joint Bone Spine; 2023 Mar; 90(2):105497. PubMed ID: 36423782
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiology and risk factors for cytomegalovirus disease in autoimmune inflammatory rheumatic diseases: A nationwide population-based study in Taiwan.
    Li TH; Su CF; Lai CC; Chang YF; Wu FY; Chang YS; Chuang CC; Tsai CY
    Int J Rheum Dis; 2024 Feb; 27(2):e15067. PubMed ID: 38402435
    [No Abstract]   [Full Text] [Related]  

  • 12. Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M
    Cacciapaglia F; Manfredi A; Erre G; Piga M; Sakellariou G; Viapiana O; Gremese E; Spinelli FR; Atzeni F; Bartoloni E
    Ann Rheum Dis; 2023 Jul; 82(7):e159. PubMed ID: 32933920
    [No Abstract]   [Full Text] [Related]  

  • 13. Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review.
    Grange L; Guilpain P; Truchetet ME; Cracowski JL;
    Therapie; 2020; 75(4):335-342. PubMed ID: 32665090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumors in rheumatic diseases].
    Świerkot J; Lewandowicz-Uszyńska A; Bogunia-Kubik K
    Postepy Hig Med Dosw (Online); 2013 Dec; 67():1254-60. PubMed ID: 24379265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correspondence on 'Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort'.
    Ruyssen-Witrand A; Soubrier M; Basch A; Truchetet ME; Seror R
    Ann Rheum Dis; 2023 Feb; 82(2):e32. PubMed ID: 33177101
    [No Abstract]   [Full Text] [Related]  

  • 16. Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Giollo A; Bertoldo E; Adami G; Cybulski AJ; Fassio A; Orsolini G; Idolazzi L; Gatti D; Viapiana O; Rossini M
    Ann Rheum Dis; 2022 Nov; 81(11):e222. PubMed ID: 32895237
    [No Abstract]   [Full Text] [Related]  

  • 17. Correspondence to: 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco
    Flood RM; Conway R; Kirby C; Gheta D; Kane DJ; Mullan RH
    Ann Rheum Dis; 2023 Jun; 82(6):e140. PubMed ID: 32816697
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence of neoplasms in the most prevalent autoimmune rheumatic diseases: a systematic review.
    Machado RI; Braz Ade S; Freire EA
    Rev Bras Reumatol; 2014; 54(2):131-9. PubMed ID: 24878860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up.
    Gamboa-Cárdenas RV; Barzola-Cerrón S; Toledo-Neira D; Reátegui-Sokolova C; Pimentel-Quiroz V; Zevallos-Miranda F; Alarcón GS; Ugarte-Gil M
    Clin Rheumatol; 2021 Nov; 40(11):4725-4734. PubMed ID: 34189675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to: 'Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries' by Nokhatha
    Dejaco C; Bijlsma JW; Buttgereit F
    Ann Rheum Dis; 2021 Oct; 80(10):e171. PubMed ID: 33509796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.